KLF4 acts in concert with OCT4, SOX2, and NANOG in hESCs (Young, 2011), but is downregulated in some breast cancer cells compared with normal mammary cells (Akaogi et al., 2009). The gene discussed is KLF4; the disease is breast cancer.